Skip to content

Neuroplasticity: all studies

Page 92 of 178: studies 911 to 920 of 1,772, newest first. Back to the neuroplasticity overview

Research

Psychedelics in Multiple Sclerosis: Mechanisms, Challenges, and Prospects for Neuroimmune Modulation and Repair.

Cells November 26, 2025 Ivan Anchesi, Maria Francesca Astorino, Ivana Raffaele et al. 1 citation

Multiple Sclerosis (MS) therapies effectively modulate peripheral immune responses but largely fail to promote neural repair within the central nervous system. This review evaluates whether psychedelic compounds (PSYs), via 5-HT2A activation, can fill a critical therapeutic gap: the need for agents that simultaneously suppress neuroinflammation and promote regeneration. We dissect the evidence...

Repeated ketamine exposure induces psychotic-like behaviors in mice via DRD1-mediated phosphorylation of p-Thr34 DARPP-32 and p-Ser10 histone H3

Cell Biology and Toxicology November 25, 2025 Peng Lv, Jiayu Zhang, Jia-Yi Wei et al.

Psychotic disorders frequently result from repeated ketamine exposure, yet the underlying mechanisms remain elusive. We propose that repeated exposure to ketamine may induce psychotic-like behaviors via DRD1-mediated nuclear signaling pathways. Our investigation focused on phosphorylated DARPP-32 at Thr34, Thr75, and Ser97, alongside transcriptome profiling in both cell and mouse models. We...

The Role of Relational Healing in Psychedelics: A Comparative Study

uO Research November 24, 2025 Wallace Murray

Psychedelics, acting primarily through 5-HT2A receptor binding and modulation of networks such as the default mode network (DMN), can induce shifts in self-perception, cognition, and emotion by promoting neuroplasticity and altering entrenched thought patterns. The biomedical model, emphasizing measurable neurochemical processes, often attempts to extract these neuroplastic benefits while...

DOI: 10.20381/ruor-31542 (opens in new tab) Reductionism Biopsychosocial model Existentialism Transformative learning +12

Successful Treatment of Exploding Head Syndrome With Ketamine.

Cureus November 23, 2025 Luiza Haruyunyan, Mitchell B. Liester, Bertrand Liang

Exploding head syndrome (EHS) is a parasomnia characterized by the perception of loud noises originating from inside the head during sleep transitions, often accompanied by visual phenomena and fear. Treatment remains challenging due to unknown etiology and limited therapeutic options. We report a 75-year-old man with chronic exploding head syndrome experiencing lightning-like sensations,...

The role of frontal EEG in predicting clinical response of major depressive disorder to intranasal ketamine and esketamine.

Journal of Affective Disorders November 22, 2025 Carlos Trenado, Erich Seifritz, Sebastian Olbrich et al. 4 citations

Ketamine and its enantiomer esketamine are NMDA receptor antagonists that have shown consistent antidepressant effects in major depression disorder (MDD). These effects suggest an active role of glutamate in the pathophysiology of depression. It has been hypothesized that acute increase of glutamate neurotransmission in the prefrontal cortex following treatment with (es)ketamine leads to...

Current perspectives on psychedelic treatments in Europe.

The Lancet Regional Health - Europe November 20, 2025 Santiago Madero, Oscar Soto-Angona, Genís Ona et al. 9 citations

In this viewpoint, we explore the evolving landscape of psychedelic-assisted therapy in Europe, focusing on clinical, regulatory, and therapeutic developments. While access remains limited, recent initiatives in Switzerland, Germany, and the Czech Republic illustrate growing momentum toward regulated use. We examine the debate surrounding psychedelics as pharmacological agents versus...

Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?

Medical Sciences November 20, 2025 Silvia Natoli, Arturo Cuomo, Maurizio Marchesini et al.

Background: Chronic pain affects nearly one in five adults worldwide and remains a major healthcare burden due to its persistence, multidimensional impact, and resistance to conventional therapies. The opioid crisis has further highlighted the urgent need for safer and more effective alternatives. Psilocybin, a serotonergic psychedelic compound, has re-emerged as a potential therapeutic option...

DOI: 10.3390/medsci13040277 (opens in new tab) Psilocybin Perspective graphical Chronic pain Clinical trial +7

Ketamine reduces microglial activation and brain monocyte infiltration and promotes peripheral regulatory immune cells, relieving lipopolysaccharide (LPS)-induced depressive-like behavior in mice.

Molecular Psychiatry November 18, 2025 A. Arena, M. R. Rubinstein, A. M. Genaro et al.

Ketamine has emerged as a rapid and sustained treatment for Major Depressive Disorder (MDD) and an alternative for patients who have not responded to traditional therapies. Its effects have been partly attributed to the noncompetitive antagonism of the N-methyl-D-aspartate receptor (NMDAR) in the central nervous system, which enhances neuroplasticity. However, the etiopathology of MDD is...

Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological Restoration

November 17, 2025 Tony R. Montgomery, Demond M. Grant

Recent research into classical psychedelics, such as psilocybin, LSD, and DMT, has highlighted their therapeutic potential for mental health disorders. However, emerging evidence suggests their utility may extend beyond treatment into the realm of preventive medicine. This manuscript proposes a novel framework positioning psychedelics as agents of cellular and psychological rejuvenation....

DOI: 10.31124/advance.175630073.36585408/v2 (opens in new tab) Rejuvenation Realm Mental health Psychological intervention +3

Principal bundle geometry of qualia: Understanding the quality of consciousness from symmetry

PsyArXiv November 14, 2025 Masafumi Oizumi, Chanseok Lim, Ryota Kanai preprint

Qualia, the subjective qualities of experience, pose a fundamental challenge to scientific explanation. A promising recent approach is to characterize qualia by their relational structures rather than their intrinsic nature. Assuming the structure of qualia is characterized by the geometry of neural representations, we posit that this geometry is fundamentally organized by symmetry. We propose...